Timmers L - Search Results

1

Patient satisfaction with information on oral anticancer agent use.

Boons CCLM, Timmers L, van Schoor NM, Swart EL, Hendrikse NH, Janssen JJWM, Hugtenburg JG. Boons CCLM, et al. Among authors: timmers l. Cancer Med. 2018 Jan;7(1):219-228. doi: 10.1002/cam4.1239. Epub 2017 Nov 23. Cancer Med. 2018. PMID: 29168352 Free PMC article.

2

The use of erlotinib in daily practice: a study on adherence and patients' experiences.

Timmers L, Boons CC, Mangnus D, Moes JE, Swart EL, Boven E, Smit EF, Hugtenburg JG. Timmers L, et al. BMC Cancer. 2011 Jul 1;11:284. doi: 10.1186/1471-2407-11-284. BMC Cancer. 2011. PMID: 21722354 Free PMC article.

3

Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008.

Timmers L, Beckeringh JJ, van Herk-Sukel MP, Boven E, Hugtenburg JG. Timmers L, et al. Pharmacoepidemiol Drug Saf. 2012 Oct;21(10):1036-44. doi: 10.1002/pds.2225. Epub 2011 Sep 29. Pharmacoepidemiol Drug Saf. 2012. PMID: 21956857

4

The use of capecitabine in daily practice: a study on adherence and patients' experiences.

Timmers L, Swart EL, Boons CC, Mangnus D, van de Ven PM, Peters GJ, Boven E, Hugtenburg JG. Timmers L, et al. Patient Prefer Adherence. 2012;6:741-8. doi: 10.2147/PPA.S36757. Epub 2012 Oct 19. Patient Prefer Adherence. 2012. PMID: 23118530 Free PMC article.

5

Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions.

Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Hugtenburg JG, et al. Among authors: timmers l. Patient Prefer Adherence. 2013 Jul 10;7:675-82. doi: 10.2147/PPA.S29549. Print 2013. Patient Prefer Adherence. 2013. PMID: 23874088 Free PMC article.

6

Adherence and patients' experiences with the use of oral anticancer agents.

Timmers L, Boons CC, Kropff F, van de Ven PM, Swart EL, Smit EF, Zweegman S, Kroep JR, Timmer-Bonte JN, Boven E, Hugtenburg JG. Timmers L, et al. Acta Oncol. 2014 Feb;53(2):259-67. doi: 10.3109/0284186X.2013.844353. Epub 2013 Nov 22. Acta Oncol. 2014. PMID: 24266637

7

Study protocol of the RAND-study: a multicenter, prospective cohort study investigating response and adherence to nilotinib treatment in chronic myeloid leukemia.

Boons CC, Swart EL, Timmers L, van de Ven PM, Janssen JJ, Hugtenburg JG. Boons CC, et al. Among authors: timmers l. BMC Cancer. 2014 Apr 8;14:247. doi: 10.1186/1471-2407-14-247. BMC Cancer. 2014. PMID: 24712728 Free PMC article. Clinical Trial.

8

Adherence, exposure and patients' experiences with the use of erlotinib in non-small cell lung cancer.

Timmers L, Boons CC, Moes-Ten Hove J, Smit EF, van de Ven PM, Aerts JG, Swart EL, Boven E, Hugtenburg JG. Timmers L, et al. J Cancer Res Clin Oncol. 2015 Aug;141(8):1481-91. doi: 10.1007/s00432-015-1935-0. Epub 2015 Mar 6. J Cancer Res Clin Oncol. 2015. PMID: 25743274 Free PMC article.

9

Adherence to oral anticancer agents: Healthcare providers' perceptions, beliefs and shared decision making in Belgium and the Netherlands.

Verbrugghe M, Timmers L, Boons CC, Van Den Bemt BJ, Hugtenburg JG, Van Hecke A. Verbrugghe M, et al. Among authors: timmers l. Acta Oncol. 2016;55(4):437-43. doi: 10.3109/0284186X.2015.1119307. Acta Oncol. 2016. PMID: 26959410

10

Adherence and Patients' Experiences with the Use of Capecitabine in Daily Practice.

Timmers L, Boons CC, Mangnus D, Van de Ven PM, Van den Berg PH, Beeker A, Swart EL, Honeywell RJ, Peters GJ, Boven E, Hugtenburg JG. Timmers L, et al. Front Pharmacol. 2016 Sep 21;7:310. doi: 10.3389/fphar.2016.00310. eCollection 2016. Front Pharmacol. 2016. PMID: 27708578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters